NVST Stock Analysis: Buy, Sell, or Hold?
NVST - Envista Holdings Corporation Common stock, $0.01 par value per share
$24.29
-2.78 (-10.27%)
▼
5d:
-6.36%
30d:
-8.89%
90d:
-1.7%
HOLD
LOW Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Smart Money Accumulation
NVST is down 6.4% this week, but smart money is accumulating calls. Top strike: $30 2026-06-18 with 6,190 OI. Call ratio: 78% View Scanner →
Strength: 6.0/10
Get Alerted When NVST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NVST shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NVST shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.67
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$24.01
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NVST is currently trading at $24.29, which is considered oversold relative to its 30-day fair value range of $25.52 to $27.28. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.6) compared to its historical average (17.5). Remarkably, the market is currently pricing in an annual earnings decline of 3.8% over the next few years. This pessimistic expectation contrasts with the company's recent 3146.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, NVST is in a strong uptrend. The price is currently testing key support at $24.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 10.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $28.69 (+18.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NVST is in a strong uptrend. The price is currently testing key support at $24.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 10.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $28.69 (+18.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$25.52 -
$27.28
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
Protect Your Profits
Holding NVST? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.3%)
- BULLISH: Trading below Wall St target ($28.69)
- CAUTION: Recommendation downgraded due to -6.4% 5-day decline
Trading Range Analysis
30-Day Trading Range
$25.52 -
$27.28
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$24.50
Resistance Level
$29.53
Current Trend
Strong Uptrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.58
Wall Street Target
$28.69
(+18.1%)
Revenue Growth (YoY)
15.0%
Earnings Growth (YoY)
3146.1%
Profit Margin
1.7%
Valuation Discount vs History
-3.8% cheaper
PE vs Historical
15.6 vs 17.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.8%
(market-implied from PE analysis)
1-Year Target
$23.37
(-4%)
2-Year Target
$22.48
(-8%)
3-Year Target
$21.62
(-11%)
3-Yr Target (if PE normalizes)
(PE: 16→18)
$24.29
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 10.5%)
$46.14
(+90%)
Base:
(SPY PE: 15.6, Growth: 10.5%)
$32.77
(+35%)
Bear:
(PE: 13.2, Growth: 10.5%)
$27.86
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Forward PE: 20.33 | Forward EPS (Implied): $1.20
Bull Case
$29.33
(+21%)
Analyst growth 15.0%, PE expands to 21.3
Base Case
$24.29
(0%)
Market implied 0.0%, PE stable at 20.3
Bear Case
$18.58
(-24%)
Severe decline -15.0%, PE contracts to 18.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.6 to 17.5
Stabilization Target:
$27.28
(+12.3%)
PE Expansion Potential:
+12.3%
Share & Embed Analysis
Last updated: May 08, 2026 9:17 AM ET
Data refreshes hourly during market hours. Next update: 10:17 AM
Data refreshes hourly during market hours. Next update: 10:17 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mischa Reis
SELL
9675 shares
2026-02-10
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$577 | 56 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 46 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$180 | 55 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$273 | 57 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 62 BUY |
Advanced NVST Option Strategies
Professional options setups generated by AI based on today's NVST price and gamma walls.
